ATX 0.00% 12.0¢ amplia therapeutics limited

Ann: Update on ACCENT Trial in Pancreatic Cancer, page-8

  1. 490 Posts.
    lightbulb Created with Sketch. 231
    there’s no doubt it looks promising and a response rate of 6/14 (43%) is on the face of it better than the MPACT trial (23%) but I’m always cautious of making comparisons between two very uneven groups. This is n=14 vs n=430 in MPACT gem/abrax arm. 30 fold difference!
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
12.0¢
Change
0.000(0.00%)
Mkt cap ! $32.97M
Open High Low Value Volume
12.3¢ 12.3¢ 12.0¢ $410 3.354K

Buyers (Bids)

No. Vol. Price($)
4 59269 12.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.5¢ 6301 1
View Market Depth
Last trade - 15.57pm 30/08/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.